Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:38 PM
NCT ID: NCT01119794
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01119794
Study Brief: Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Ofatumumab IV, Ofatumumab 1000 mg IV Cycle 1 on day 1, 8, 15 and 22, Ofatumumab and Bortezomib: Ofatumumab 1000 mg IV Cycle 1 on day 1, 8, 15 and 22- in the induction phase Ofatumumab 1000 mg IV on day 1- will receive in the maintenance phase Patients will remain until progression None None 1 10 10 10 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
nausea SYSTEMATIC_ASSESSMENT Investigations None View
vomitting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
infusion reaction SYSTEMATIC_ASSESSMENT Investigations None View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
glucose SYSTEMATIC_ASSESSMENT Investigations None View
abdominal pain SYSTEMATIC_ASSESSMENT Investigations None View
nausea SYSTEMATIC_ASSESSMENT Investigations None View
shortness of breath SYSTEMATIC_ASSESSMENT Investigations None View
edema SYSTEMATIC_ASSESSMENT Investigations None View
fatigue SYSTEMATIC_ASSESSMENT Investigations None View
white blood cell decrease SYSTEMATIC_ASSESSMENT Investigations None View
general pain SYSTEMATIC_ASSESSMENT General disorders None View
rash SYSTEMATIC_ASSESSMENT Investigations None View
derm skin other SYSTEMATIC_ASSESSMENT Investigations None View
anemia SYSTEMATIC_ASSESSMENT Investigations None View
thrombocytopenia SYSTEMATIC_ASSESSMENT Investigations None View
neuropathy SYSTEMATIC_ASSESSMENT Investigations None View
constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
neutropenia SYSTEMATIC_ASSESSMENT Investigations None View
Red blodd cell SYSTEMATIC_ASSESSMENT Investigations None View
Lymphopenia SYSTEMATIC_ASSESSMENT Investigations None View
hyponatremia SYSTEMATIC_ASSESSMENT Investigations None View
Liver function test abnormalities SYSTEMATIC_ASSESSMENT Investigations None View
muscle aches SYSTEMATIC_ASSESSMENT General disorders None View
phosphorus SYSTEMATIC_ASSESSMENT Investigations None View
sweating SYSTEMATIC_ASSESSMENT Investigations None View
mood alteration SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
phlebitis SYSTEMATIC_ASSESSMENT Investigations None View
creatinine SYSTEMATIC_ASSESSMENT Investigations None View
dehydration SYSTEMATIC_ASSESSMENT Investigations None View
hip pain SYSTEMATIC_ASSESSMENT Investigations None View
cough SYSTEMATIC_ASSESSMENT Investigations None View
back pain SYSTEMATIC_ASSESSMENT Investigations None View
heartburn SYSTEMATIC_ASSESSMENT Investigations None View
upper respiratory infection SYSTEMATIC_ASSESSMENT Investigations None View